NASDAQ:APGE

Apogee Therapeutics Stock Forecast

etoro logo Buy APGE
*Your capital is at risk
$132.55
+42.17 (+46.66%)
At Close: Jun 22, 2026
AI Analysis AI Analysis of APGE AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add APGE to Watchlist?
Some Reasons Why To Add APGE:
  • +220.6% price growth over the last year
  • Beat earnings estimates in 3 of the last 4 quarters
  • +74.9% YTD performance
PDF

Strong day for Apogee Therapeutics, Inc. stock price on Monday rising 46.66% to $132.55
(Updated on Jun 22, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 11, 2026 Gain 48.10%

The Apogee Therapeutics, Inc. stock price gained 46.66% on the last trading day (Monday, 22nd Jun 2026), rising from $90.38 to $132.55. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 0.377% from a day low at $132.50 to a day high of $133.00. The price has been going up and down for this period, and there has been a 52.5% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 60 million more shares were traded than the day before. In total, 61 million shares were bought and sold for approximately $8.11 billion.

The stock has broken the wide and weak rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $96.62, a level that may pose a second chance to hit a runner.

APGE Signals & Forecast

The Apogee Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $94.37 and $84.78. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, May 27, 2026, and so far it has risen 70.48%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Apogee Therapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.500 between high and low, or 0.377%. For the last week, the stock has had daily average volatility of 3.74%.

The Apogee Therapeutics, Inc. stock is extremely overbought on RSI14 (82). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: $128.10 (-3.36%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 82 and this increases the risk substantially. There is a buy signal from a pivot bottom found 17 days ago.)

Trading Expectations (APGE) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Apogee Therapeutics, Inc. to open at $132.68, and during the day (based on 14 day Average True Range), to move between $128.86 and $136.24, which gives a possible trading interval of +/-$7.39 (+/-5.73%) up or down from last closing price. If Apogee Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.73% move between the lowest and the highest trading price during the day.

Is Apogee Therapeutics, Inc. stock A Buy?

Apogee Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $132.68 ( 0.101%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

APGE Performance

Trading levels for APGE

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 133.18 0.478%
R2 132.99 0.334%
R1 132.87 0.245%
Price 132.55
S1 132.49 -0.0435%
S2 132.37 -0.133%
S3 132.18 -0.277%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 132.55
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Apogee Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Apogee Therapeutics, Inc. is APGE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Apogee Therapeutics, Inc. Stock?
Apogee Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy Apogee Therapeutics, Inc. Stock?
Apogee Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Apogee Therapeutics, Inc. Stock.

What's the current price of Apogee Therapeutics, Inc. Stock?
As of the end of day on the Jun 22, 2026, the price of an Apogee Therapeutics, Inc. (APGE) share was $132.55.

What is the 52-week high and low for Apogee Therapeutics, Inc. Stock?
The 52-week high for Apogee Therapeutics, Inc. Stock is $133.00 and the 52-week low is $34.34.

What is the market capitalization of Apogee Therapeutics, Inc. Stock?
As of the Jun 22, 2026, the market capitalization of Apogee Therapeutics, Inc. is 8.205B.

When is the next earnings date for Apogee Therapeutics, Inc.?
The upcoming earnings date for Apogee Therapeutics, Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE